OR WAIT null SECS
The temperature-controlled containers will be introduced across all flights for large pharma shipments
Etihad Cargo has approved the use of CSafe Global’s high-performing container, the CSafe RAP, across its global fleet of wide-body and freighter aircraft. CSafe Global provides end-to-end thermal shipping for the pharmaceutical and life science industries with a presence in more than 150 countries.
The CSafe RAP uses new heating and compressor-driven cooling technologies, along with advanced VIP insulation, to maintain constant payload temperatures even at extreme ambient temperatures spanning from -30°C to +54°C – reportedly the broadest operating range in the industry.
Its large payload compartment of 6.68 cubic meters (235.902 cubic feet) accommodates up to four standard U.S. pallets or five standard Euro pallets. With an extended battery run time of more than 120 hours, the CSafe RAP provides temperature integrity and product viability through to destination, including on extended journeys.
Etihad Cargo recently reinforced its pharmaceutical logistics capabilities with the launch of PharmaLife, a specialized pharma and healthcare service that comprises both active and passive containers and associated ground services. It was the first carrier in the Middle East to receive the IATA's Center of Excellence for Independent Validators (CEIV) certification in pharmaceutical logistics.
“We are confident as market demands become stronger for vaccines and clinical trials that we are ready to offer quality along with enough capacity to our customers,” said Fabrice Panza, global cold chain manager at Etihad Cargo.
Etihad Cargo, the cargo and logistics arm of the Etihad Aviation Group, has been a long-time partner with CSafe Global and provides a number of closed cold-chain solutions, including the CSafe RAP and CSafe RKN. Sale and leasing options for the containers are available through Etihad Cargo.